Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Neuroimmunol ; 277(1-2): 6-12, 2014 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-25468273

RESUMO

Natalizumab-induced progressive multifocal leukoencephalopathy appears to be unleashed by complex interactions between viral and immunological host factors leading the latent form of JC virus to become pathogenic. Positive anti-JC virus antibody status, prior use of immunosuppressants, and increasing duration of natalizumab treatment have been proposed as risk factors for progressive multifocal leukoencephalopathy in multiple sclerosis patients, but while they may help to identify the most appropriate patients for natalizumab, their use have some limitations. Therefore, a large body of studies is ongoing to identify alternative, reliable immunological markers capable to improve the safety and efficacy of therapy, and to guide tailored clinical decisions.


Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Fatores Imunológicos/efeitos adversos , Leucoencefalopatia Multifocal Progressiva , Biomarcadores , Humanos , Vírus JC/imunologia , Leucoencefalopatia Multifocal Progressiva/induzido quimicamente , Leucoencefalopatia Multifocal Progressiva/diagnóstico , Leucoencefalopatia Multifocal Progressiva/imunologia , Esclerose Múltipla/tratamento farmacológico , Natalizumab , Fatores de Risco
2.
J Immunol Res ; 2014: 240453, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25756054

RESUMO

Levels of Kappa-deleting recombination excision circles (KRECs), T-cell receptor excision circles (TRECs), and T-cell repertoire diversity were evaluated in 1038 samples of 124 children with primary immunodeficiency, of whom 102 (54 with severe combined immunodeficiency and 48 with other types of immunodeficiency) underwent hematopoietic stem cell transplantation. Twenty-two not transplanted patients with primary immunodeficiency were used as controls. Only data of patients from whom at least five samples were sent to the clinical laboratory for routine monitoring of lymphocyte reconstitutions were included in the analysis. The mean time of the follow-up was 8 years. The long-lasting posttransplantation kinetics of KREC and TREC production occurred similarly in patients with severe combined immunodeficiency and with other types of immunodeficiency and, in both groups, the T-cell reconstitution was more efficient than in nontransplanted children. Although thymic output decreased in older transplanted patients, the degree of T-cell repertoire diversity, after an initial increase, remained stable during the observation period. However, the presence of graft-versus-host disease and ablative conditioning seemed to play a role in the time-related shaping of T-cell repertoire. Overall, our data suggest that long-term B- and T-cell reconstitution was equally achieved in children with severe combined immunodeficiency and with other types of primary immunodeficiency.


Assuntos
Linfócitos B/imunologia , Transplante de Células-Tronco Hematopoéticas , Síndromes de Imunodeficiência/imunologia , Receptores de Antígenos de Linfócitos T/genética , Linfócitos T/imunologia , Adolescente , Adulto , Criança , Feminino , Seguimentos , Variação Genética , Humanos , Síndromes de Imunodeficiência/terapia , Imunofenotipagem , Linfopoese/genética , Masculino , Recombinação Genética , Estudos Retrospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA